Skip to menu Skip to content Skip to footer

2025

Conference Publication

Identifying disease-modifying therapies in myeloproliferative neoplasms

Bywater, Megan, Zhang, Ranran, Haldar, Rohit, Cooper, Emily, Chan, Siu Hang Natalie, Janardhanan, Yashaswini, Cooper, Leanne, Straube, Jasmin and Steven, Lane (2025). Identifying disease-modifying therapies in myeloproliferative neoplasms. 54th Annual Scientific Meeting of the ISEH - International Society for Experimental Hematology, Kumamoto, Japan, 24-27 September 2025. Amsterdam, Netherlands: Elsevier. doi: 10.1016/j.exphem.2025.105051

Identifying disease-modifying therapies in myeloproliferative neoplasms

2024

Conference Publication

3035 – INTERFERON ALPHA THERAPY ATTENUATES LEUKAEMIC TRANSFORMATION IN JAK2V617F-DRIVEN MPN WITH TRP53-LOSS

Bywater, Megan, Zhang, Ranran, Grabek, Julian, Halder, Rohit, Janardhanan, Yashaswini, Cooper, Leanne, Cooper, Emily, Ross, David, Straube, Jasmin and Lane, Steven (2024). 3035 – INTERFERON ALPHA THERAPY ATTENUATES LEUKAEMIC TRANSFORMATION IN JAK2V617F-DRIVEN MPN WITH TRP53-LOSS. EXPHEM 2024, Philadelphia, PA, United States: Elsevier BV. doi: 10.1016/j.exphem.2024.104357

3035 – INTERFERON ALPHA THERAPY ATTENUATES LEUKAEMIC TRANSFORMATION IN JAK2V617F-DRIVEN MPN WITH TRP53-LOSS

2023

Conference Publication

Trp53-Loss in Hematopoietic Stem Cells Drives the Evolutionary Process of Leukemic Transformation in a Jak2 V617F-Driven Myeloproliferative Neoplasms Mouse Model

Zhang, Ranran, Janardhanan, Yashaswini, Haldar, Rohit, Cooper, Leanne, Jaquelin, Sebastien, Straube, Jasmin, Bywater, Megan and Lane, Steven W. (2023). Trp53-Loss in Hematopoietic Stem Cells Drives the Evolutionary Process of Leukemic Transformation in a Jak2 V617F-Driven Myeloproliferative Neoplasms Mouse Model. 65th ASH Annual Meeting, San Diego, CA United States, 9-12 December 2023. Washington, DC United States: American Society of Hematology. doi: 10.1182/blood-2023-188150

Trp53-Loss in Hematopoietic Stem Cells Drives the Evolutionary Process of Leukemic Transformation in a Jak2 V617F-Driven Myeloproliferative Neoplasms Mouse Model

2019

Conference Publication

Germline RUNX1 variation and predisposition to T-cell acute lymphoblastic leukemia in children

Li, Yizhen, Qian, Maoxiang, Devidas, Meenakshi, Yang, Wentao, Winter, Stuart S., Dunsmore, Kimberly P., Smith, Colton A., Lin, Ting-Nien, Zhao, Xuijie, Zhang, Ranran, Foster, Julie M. Gastier, Raetz, Elizabeth A., Carroll, William L., Rabin, Karen R., Yang, Wenjian, Zweidler-McKay, Patrick A., Pui, Ching-Hon, Evans, William E., Mullighan, Charles G., Hunger, Stephen P., Relling, Mary V., Loh, Mignon L. and Yang, Jun J. (2019). Germline RUNX1 variation and predisposition to T-cell acute lymphoblastic leukemia in children. 61st Annual Meeting of the American-Society-of-Hematology (ASH), Orlando, FL, United States, 7-10 December 2019. Washington, DC, United States: American Society of Hematology. doi: 10.1182/blood-2019-125912

Germline RUNX1 variation and predisposition to T-cell acute lymphoblastic leukemia in children

2016

Conference Publication

Whole transcriptome sequencing identified a distinct subtype of acute lymphoblastic leukemia with abnormalities of CREBBP and EP300

Zhang, Hui, Qian, Maoxiang, Shirley,, Kham, Kow Yin, Liu, Shuguang, Jiang, Chuang, Zhao, Xujie, Lu, Yi, Lin, Ting-Nien, Zhang, Ranran, Moriyama, Takaya, Yin, Zhaohong, Shi, Lei, Li, Zhenhua, Chiew, Kean-Hui, Chen, Zhiwei, Deepa, Bhojwani, Shen, Shuhong, Zheng, Huyong, Pui, Ching-Hon, Yeoh, Allen Eng Juh and Yang, Jun J. (2016). Whole transcriptome sequencing identified a distinct subtype of acute lymphoblastic leukemia with abnormalities of CREBBP and EP300. 58th Annual Meeting and Exposition of the American Society of Hematology (ASH), San Diego, CA, United States, 3-6 December 2016. Washington, DC, United States: American Society of Hematology. doi: 10.1182/blood.v128.22.3912.3912

Whole transcriptome sequencing identified a distinct subtype of acute lymphoblastic leukemia with abnormalities of CREBBP and EP300

2016

Conference Publication

Chemosensitizing effect of Fenretinide-induced NF-κb inhibition in AML therapy

Zhang, Ranran, Fenggui, Wei, Chen, Ru, Liang, Ming, Wu, Liping, Zhang, Hui and Chen, Fuxiong (2016). Chemosensitizing effect of Fenretinide-induced NF-κb inhibition in AML therapy. 58th ASH Annual Meeting, San Diego, CA United States, 3-6 December 2016. Washington, DC United States: American Society of Hematology. doi: 10.1182/blood.v128.22.1580.1580

Chemosensitizing effect of Fenretinide-induced NF-κb inhibition in AML therapy

2016

Conference Publication

Germline genetic variation in IKZF1 and predisposition to childhood acute lymphoblastic leukemia

Churchman, Michelle L., Qian, Maoxiang, Zhang, Ranran, Kronnie, Geertruy, Yang, Wenjian, Zhang, Hui, Lana, Tobia, Tedrick, Paige, Baskin, Rebekah, Verbist, Katherine, Devidas, Meenakshi, Raetz, Elizabeth, Larsen, Eric, Martin, Paul L., Bowman, W. Paul, Winick, Naomi, Mardis, Elaine R, Fulton, Robert S., Stanulla, Martin, Evans, William E., Relling, Mary V., Pui, Ching-Hon, Handgretinger, Rupert, Hunger, Stephen P., Loh, Mignon L., Nichols, Kim E., Mullighan, Charles and Yang, Jun J. (2016). Germline genetic variation in IKZF1 and predisposition to childhood acute lymphoblastic leukemia. 58th ASH Annual Meeting, San Diego, CA, United States, 3-6 December 2016. Washington, DC, United States: American Society of Hematology. doi: 10.1182/blood.v128.22.lba-2.lba-2

Germline genetic variation in IKZF1 and predisposition to childhood acute lymphoblastic leukemia